Prioritize hygiene and safety in your workplace with compliant facilities. Connect with BioBoston Consulting for expert guidance on regulatory compliance.
Facilities Compliance in the pharmaceutical manufacturing is critical to ensure the safety and efficacy of the drugs. . Guidelines are thus imposed by regulatory authorities to maintain the quality of pharmaceutical products within the industry. The standard regulation is provided by the Code of Federal Regulations (CFR) in Part 211: Current Good Manufacturing Practice for Finished Pharmaceuticals.
Essential Requirements for Washing and Toilet Facilities:
Subpart C of Section 211.52 demands that pharmaceutical manufacturers provide adequate washing and toilet facilities to ensure hygiene and cleanliness in the environment where the manufacturing is performed. Ensuring compliance with these specifications can prevent contaminationand protect employees’ health and well-being. Let us take a more in-depth look at the major requirements set forth by the regulation.
Adequate washing and toilet facilities:
This underpins good manufacturing practice, which results in a clean environment. These will prevent contamination, among other things, and assure the health and safety of employees. Let us examine now the different essential elements of these facilities according to the regulation.There should be an adequate supply of washing facilities in manufacturing areas.. This requires both hot and cold-water supply to adequately facilitate hand washing practices. Hot water wash removes dirt and micro-organisms while offering a refreshing rinse with cold-water.
Soap or Detergent:
Soap or detergent should be made readily available at handwashing stations to support proper hand hygiene. Soap and detergents will lift dirt, oils, and microorganisms from the skin that otherwise may be transferred onto surfaces during the manufacturing process.
Air driers or single-service towels:
In case hand washing has been performed, air driers or single-service towels should be available to dry the hands. This ensures minimal transfer of bacteria, which can result from shared towels.
Systematic Receipt and Dispatch Procedure
The regulation demands that procedures for authorization receipt from and dispatch to storage areas and stockrooms be provided. Good and well-defined procedures regarding receipt and dispatch enhance traceability and accountability while reducing the risks of misplaced and mismanaged medical devices at every step involved with receiving and dispatching them. Proper documentation for the receipt and dispatch activities proves crucial in establishing authenticity and allowing smoother facilitation in case of recalls and compliance with the regulatory assessment.
Clean Toilet Facilities Pharmaceutical manufacturing facilities shall provide clean and well-maintained toilet facilities within easy access to working areas. The toilet facilities shall be frequently cleaned and provided with adequate toilet paper and well-ventilated.. Adequate sanitation shall ensure a healthy safe environment and promote comfort and well-being for employees.
At conveniently accessible working areas: These facilities should be placed at conveniently accessible to the working areas to facilitate convenience and encourage compliance. This will reduce the time and effort exerted by employees in observing proper hygiene practices to support manufacturing operations.
Significance of Compliance:
The storage regulations provide that pharmaceutical manufacturers face severe penalties when they fail to obey the provisions of those regulations. That may include issuance of warning letters, fines, product recalls, suspension of production and distribution or loss of goodwill based on inadequate quality products, which leads to loss of trust from healthcare providers and patients as well as other stakeholders. Therefore, to avert such incidences, pharmaceutical firms must strictly abide by the provisions in Subpart L.
Regulatory Compliance and Industry Standards
Pharmaceutical manufacturers need to assess their facilities, processes, and procedures at appropriate intervals for conformity with the cGMP guidelines.. Among the subparts included in Part 211 of those cGMP guidelines, the one dealing with washing and toilet facilities holds significant importance. Such implementation and maintenance of adequate washing and toilet facilities would validate that manufacturers follow proper standards in delivering quality finished pharmaceuticals products with safety standards.
Part 211, Good Manufacturing Practice for Finished Pharmaceuticals, Subpart C Buildings and Facilities, describes the essential guiding principles of the pharmaceutical manufacturing industry. Compliance of the provision for washing and toilet facilities ensures hygiene and safety of the employees and integrity in the manufacturing process.
Contact BioBoston Consulting now or visit our website to learn more about how we can help you with your regulatory activities.
